Terms: = Liver cancer AND KLF4, EZF, 9314, ENSG00000136826, GKLF, O43474 AND Treatment
30 results:
1. Apoptosis antagonizing transcription factor-mediated liver damage and inflammation to cancer: Therapeutic intervention by curcumin in experimental metabolic dysfunction associated steatohepatitis-hepatocellular carcinoma.
Srinivas AN; Suresh D; Chidambaram SB; Santhekadur PK; Kumar DP
J Cell Physiol; 2024 Jan; 239(1):135-151. PubMed ID: 37942831
[TBL] [Abstract] [Full Text] [Related]
2. CircHULC accelerates the growth of human liver cancer stem cells by enhancing chromatin reprogramming and chromosomal instability via autophagy.
Song S; Wang L; Jiang X; Liu X; Li S; Xie S; Lu D
Cell Signal; 2023 Sep; 109():110772. PubMed ID: 37321526
[TBL] [Abstract] [Full Text] [Related]
3. ABI2-mediated MEOX2/klf4-NANOG axis promotes liver cancer stem cell and drives tumour recurrence.
Chen J; Li H; Zhang B; Xiong Z; Jin Z; Chen J; Zheng Y; Zhu X; Zhang S
Liver Int; 2022 Nov; 42(11):2562-2576. PubMed ID: 36017822
[TBL] [Abstract] [Full Text] [Related]
4. Oncofetal proteins and cancer stem cells.
Yan Q; Fang X; Li C; Lan P; Guan X
Essays Biochem; 2022 Sep; 66(4):423-433. PubMed ID: 35670043
[TBL] [Abstract] [Full Text] [Related]
5. klf4 Alleviates Hypertrophic Scar Fibrosis by Directly Activating BMP4 Transcription.
Wang J; Zhao M; Zhang H; Yang F; Luo L; Shen K; Wang X; Li Y; Zhang J; Zhang J; Wang K; Li J; Wang Y; Yang Y; Hu D
Int J Biol Sci; 2022; 18(8):3324-3336. PubMed ID: 35637963
[No Abstract] [Full Text] [Related]
6. Epigenetic regulation of the DNMT1/MT1G/klf4/CA9 axis synergises the anticancer effects of sorafenib in hepatocellular carcinoma.
Wei T; Lin R; Fu X; Lu Y; Zhang W; Li Z; Zhang J; Wang H
Pharmacol Res; 2022 Jun; 180():106244. PubMed ID: 35550167
[TBL] [Abstract] [Full Text] [Related]
7. USP11 degrades klf4 via its deubiquitinase activity in liver diseases.
Yang H; Park D; Ryu J; Park T
J Cell Mol Med; 2021 Jul; 25(14):6976-6987. PubMed ID: 34114341
[TBL] [Abstract] [Full Text] [Related]
8. Doxorubicin-induced senescence promotes stemness and tumorigenicity in EpCAM-/CD133- nonstem cell population in hepatocellular carcinoma cell line, HuH-7.
Karabicici M; Alptekin S; Fırtına Karagonlar Z; Erdal E
Mol Oncol; 2021 Aug; 15(8):2185-2202. PubMed ID: 33524223
[TBL] [Abstract] [Full Text] [Related]
9. Romidepsin hepatocellular carcinoma suppression in mice is associated with deregulated gene expression of bone morphogenetic protein and Notch signaling pathway components.
Afaloniati H; Poutahidis T; Giakoustidis A; Gargavanis A; Giakoustidis D; Angelopoulou K
Mol Biol Rep; 2021 Jan; 48(1):551-562. PubMed ID: 33393006
[TBL] [Abstract] [Full Text] [Related]
10. LRH-1 (liver receptor homolog-1) derived affinity peptide ligand to inhibit interactions between β-catenin and LRH-1 in pancreatic cancer cells: from computational design to experimental validation.
Pouraghajan K; Mahdiuni H; Ghobadi S; Khodarahmi R
J Biomol Struct Dyn; 2022 Apr; 40(7):3082-3097. PubMed ID: 33183172
[TBL] [Abstract] [Full Text] [Related]
11. The association between klf4 as a tumor suppressor and the prognosis of hepatocellular carcinoma after curative resection.
Xue M; Zhou C; Zheng Y; Zhang Z; Wang S; Fu Y; Atyah M; Xue X; Zhu L; Dong Q; Jia H; Ren N; Hu R
Aging (Albany NY); 2020 Aug; 12(15):15566-15580. PubMed ID: 32756012
[TBL] [Abstract] [Full Text] [Related]
12. A Novel Function for klf4 in Modulating the De-differentiation of EpCAM
Karagonlar ZF; Akbari S; Karabicici M; Sahin E; Avci ST; Ersoy N; Ates KE; Balli T; Karacicek B; Kaplan KN; Celiker C; Atabey N; Erdal E
Cells; 2020 May; 9(5):. PubMed ID: 32408542
[TBL] [Abstract] [Full Text] [Related]
13. Elevated PDK1 Expression Drives PI3K/AKT/MTOR Signaling Promotes Radiation-Resistant and Dedifferentiated Phenotype of Hepatocellular Carcinoma.
Bamodu OA; Chang HL; Ong JR; Lee WH; Yeh CT; Tsai JT
Cells; 2020 Mar; 9(3):. PubMed ID: 32197467
[TBL] [Abstract] [Full Text] [Related]
14. Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma.
Liu L; Yang X; Li NF; Lin L; Luo H
Cell Cycle; 2019 Nov; 18(21):2939-2953. PubMed ID: 31522588
[No Abstract] [Full Text] [Related]
15. Aberrant lipid metabolism as a therapeutic target in liver cancer.
Pope ED; Kimbrough EO; Vemireddy LP; Surapaneni PK; Copland JA; Mody K
Expert Opin Ther Targets; 2019 Jun; 23(6):473-483. PubMed ID: 31076001
[TBL] [Abstract] [Full Text] [Related]
16. GATA5 inhibits hepatocellular carcinoma cells malignant behaviours by blocking expression of reprogramming genes.
Feng H; Zhu M; Zhang R; Wang Q; Li W; Dong X; Chen Y; Lu Y; Liu K; Lin B; Guo J; Li M
J Cell Mol Med; 2019 Apr; 23(4):2536-2548. PubMed ID: 30672133
[TBL] [Abstract] [Full Text] [Related]
17. MicroRNA‑9‑5p downregulates klf4 and influences the progression of hepatocellular carcinoma via the AKT signaling pathway.
Dong X; Wang F; Xue Y; Lin Z; Song W; Yang N; Li Q
Int J Mol Med; 2019 Mar; 43(3):1417-1429. PubMed ID: 30664155
[TBL] [Abstract] [Full Text] [Related]
18. The therapeutic potential of induced hepatocyte-like cells generated by direct reprogramming on hepatic fibrosis.
Park S; In Hwang S; Kim J; Hwang S; Kang S; Yang S; Kim J; Kang W; Kim KH; Han DW; Paik YH
Stem Cell Res Ther; 2019 Jan; 10(1):21. PubMed ID: 30635054
[TBL] [Abstract] [Full Text] [Related]
19. SF3B4 is regulated by microRNA-133b and promotes cell proliferation and metastasis in hepatocellular carcinoma.
Liu Z; Li W; Pang Y; Zhou Z; Liu S; Cheng K; Qin Q; Jia Y; Liu S
EBioMedicine; 2018 Dec; 38():57-68. PubMed ID: 30391496
[TBL] [Abstract] [Full Text] [Related]
20. Combined treatment with sorafenib and silibinin synergistically targets both HCC cells and cancer stem cells by enhanced inhibition of the phosphorylation of STAT3/ERK/AKT.
Mao J; Yang H; Cui T; Pan P; Kabir N; Chen D; Ma J; Chen X; Chen Y; Yang Y
Eur J Pharmacol; 2018 Aug; 832():39-49. PubMed ID: 29782854
[TBL] [Abstract] [Full Text] [Related]
[Next]
